00950 LEE'S PHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.03X | Oper Margin | 6.0% |
|---|---|---|---|
| LT Debt/Equity | 4.3% | Net Margin | 6.4% |
| Total Debt/Equity | 15.2% | Return on Equity | 4.5% |
| Price/Book | 0.35X | Return on Assets | 2.7% |
| (HKD 1.210) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 91.94 | 93.10 | 16.70 | 51.28 | 1,987.18 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -1.3 | +457.6 | -67.4 | -97.4 | +1,436.7 |
| Earnings Per Share (HKD) | 0.156 | 0.158 | 0.028 | 0.087 | 3.376 |
| Earnings Per Share Growth (%) | -1.3 | +456.7 | -67.4 | -97.4 | +1,435.2 |
| Dividend Per Share (HKD) | 0.045 | 0.045 | 0.018 | 0.020 | 0.061 |
| P/E* (X) | 7.75 | 7.65 | 42.61 | 13.89 | 0.36 |
| Yield (%) | 3.72 | 3.72 | 1.49 | 1.65 | 5.04 |
| Dividend Share (%) | 28.83 | 28.46 | 63.38 | 22.96 | 1.81 |
| Book NAV (HKD) | 3.474 | 2.805 | 3.463 | 3.268 | 4.186 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (HKDMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,436 | 1,400 | +2.6 | 1,053 |
| Operating Result | 100.926 | 98.815 | +2.1 | -10.125 |
| Associates | -1.847 | -0.839 | +120.1 | -0.87 |
| Profit Before Taxation | 72.886 | 98.113 | -25.7 | 30.785 |
| Taxation | 22.27 | 29.501 | -24.5 | 10.836 |
| Profit /( Loss) After Taxation | 50.616 | 68.612 | -26.2 | 19.949 |
| Minority Interests | -41.322 | -24.487 | +68.8 | 3.251 |
| Net Profit | 91.938 | 93.099 | -1.2 | 16.698 |
| Earnings Per Share () | 0.1561 | 0.1581 | -1.3 | 0.0284 |
| Dividend Per Share () | 0.0450 | 0.0450 | +0.0 | 0.0180 |
| Announcement Date | 2026-03-30 | 2025-03-27 | NA | 2024-03-26 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
